Latest news about Centenial Surgical Suture
Centenial Surgical Suture
92.85
-4.65(-4.77%)
Company Performance:
View Company Insights1D-4.77%
1M+9.75%
6M+7.32%
1Y-39.09%
5Y+77.53%
More news about Centenial Surgical Suture
16Apr 26
Centenial Surgical Suture Ltd Submits Q4FY26 Compliance Certificate Under SEBI Depositories Regulations
Centenial Surgical Suture Ltd filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) with BSE Limited on April 16, 2026. The certificate, issued by registrar Purva Sharegistry (I) Private Limited, confirms proper processing of dematerialisation requests during the quarter ended March 31, 2026, with all securities handled within prescribed timelines and appropriate procedures followed for certificate cancellation and member register updates.
17Mar 26
Centenial Surgical Suture Ltd Alleges Price Manipulation in Response to BSE Surveillance Inquiry
Centenial Surgical Suture Ltd responded to BSE surveillance inquiry dated March 13, 2026, alleging systematic price manipulation through suspicious small-lot transactions by investors across India. The company provided detailed trading data from January-March 2026 and requested comprehensive investigation, emphasizing no material announcements justified the price movements and confirming management has no involvement in the alleged activities.
17Feb 26
Centenial Surgical Suture Files BSE Complaint Alleging Price Manipulation in Scrip 531308
Centenial Surgical Suture Ltd has filed a formal complaint with BSE alleging price manipulation in scrip 531308 during February 06-13, 2026. The company reported suspicious small-volume trading activities and requested investigation into potential SEBI regulation violations, while denying any involvement by company insiders in the alleged manipulative practices.
12Feb 26
Centenial Surgical Suture Ltd. Board Approves Q3FY26 Financial Results
Centenial Surgical Suture Ltd. board approved standalone unaudited financial results for the quarter and nine months ended December 31, 2025, during a 20-minute meeting on February 12, 2026. The approval was conducted in compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, with proper regulatory disclosure made to BSE Limited.
10Oct 25
Centenial Surgical Suture Ltd Strengthens Audit Committee with New Appointment
Centenial Surgical Suture Ltd has appointed Neel Vora, an Independent Non-Executive Director, to its Audit Committee effective October 10, 2025. The appointment was made through a Circular Resolution passed by the Board of Directors. The reconstituted Audit Committee now comprises four members: Akash Modi (Chairman), Ridhima Limaye, Neel Vora, and Vijay Majrekar. This change aligns with the company's efforts to maintain high standards of financial oversight and transparency.
Industry Peers
Poly Medicure
Tarsons Products
Q-Line Biotech
Laxmi Dental
Osel Devices
Vasa Denticity
Fabtech Technologies
Hemant Surgical Industries
Prevest Denpro
Nureca
1,737.20
(+1.04%)
346.85
(+0.55%)
553.70
(+0.72%)
194.99
(-1.59%)
420.60
(+5.01%)
413.00
(+4.40%)
147.05
(+0.16%)
373.30
(+6.37%)
403.00
(-0.60%)
300.40
(-2.05%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
